Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Ophthalmology

Standard of Care Treatment for Mooren Ulcer

At a Glance

Mooren ulcer treatment is individualized: intensive steroid eye drops often come first, while systemic immune-suppressing medicines or biologics may be used for progressive or bilateral disease. Antivirals and surgery may be needed to treat infection or protect a thinned cornea.

The primary goal of treating Mooren ulcer is to stop the immune system from “melting” the corneal tissue [1]. Because the disease is rare and there is no universally accepted protocol, management is highly individualized. Doctors use a tailored approach, which may involve local eye drops and body-wide medications depending on the severity, laterality, and specific features of your case [2][1].

First-Line: Topical Corticosteroids

For many patients, the first line of defense is intensive topical corticosteroids (steroid eye drops) [2]. These work by locally quieting the immune cells that are attacking the cornea [3].

While effective at reducing inflammation, long-term or high-dose steroid use requires extremely close monitoring for two major risks:

  • Secondary Infection: Steroids dampen the eye’s natural defenses, which can allow “opportunistic” infections like fungi or viruses (such as Herpes Simplex Virus) to take hold [4][5]. A “feathery” or milky appearance in the ulcer during treatment may signal a fungal infection. Never start, increase, or restart steroid drops on your own, as they can worsen infections. Promptly report any new white areas or discharge.
  • Eye Pressure: Some patients are “steroid responders,” meaning the drops can cause a dangerous increase in eye pressure (glaucoma) [6].

Step-Up Therapy: Systemic Immunosuppression

If the ulcer continues to progress despite eye drops, or if the disease is present in both eyes (bilateral), doctors often prescribe systemic immunosuppressants [1]. These medications are taken as pills, injections, or infusions to suppress the immune system throughout the entire body [7].

Common systemic medications (often prescribed off-label based on limited studies due to the disease’s rarity) include:

  • Systemic Corticosteroids: Oral steroids used to gain rapid control of inflammation.
  • Methotrexate, Cyclophosphamide, and Cyclosporine: These are steroid-sparing agents that may be utilized based on specialist judgment to provide long-term control [1][8][9][10].

Note: While mycophenolate mofetil (MMF) is used in many other eye diseases, its evidence specifically for Mooren ulcer is currently very limited, but it may still be considered as an off-label option by your specialist [3][11].

Medication Safety and Monitoring

These are potent medications. Depending on the drug, monitoring may include regular blood counts, liver function tests, and kidney tests. Promptly report fever, unusual bruising, or blood in your urine, and discuss pregnancy or vaccines with your prescribing team.

Advanced Options: Biologics

In severe cases where conventional drugs fail (refractory disease), specialists may turn to biologics [12]. These uses are specialist-directed and often based on small studies.

  • Rituximab and Infliximab are given by infusion, whereas Adalimumab is typically given by injection [12][13][14]. These advanced therapies target specific inflammatory proteins but also require rigorous infection screening and specialist monitoring.

The Infection Pivot

A Mooren ulcer can sometimes be complicated by a “hidden” infection, most commonly the Herpes Simplex Virus (HSV) [5]. If your doctor finds evidence of a virus while you are on immune-suppressing drugs, they must “pivot” your treatment plan [5]. This usually involves adding antiviral medications (like acyclovir) while carefully balancing the use of steroids to ensure the infection doesn’t spread [5][10].

Surgical Support

While medications do the heavy lifting to stop the disease, surgery is often necessary to physically support a thinned cornea. This can range from applying cyanoacrylate glue to seal small leaks to performing a corneal transplant [15][6]. A perforation or impending perforation may require urgent tectonic repair before inflammation is fully quiet.

Common questions in this guide

What is usually the first treatment for Mooren ulcer?
Doctors often start with intensive corticosteroid eye drops to calm the immune attack on the cornea. The drops require close follow-up because they can raise eye pressure and can make some infections harder to recognize or control.
When are whole-body immune-suppressing medicines used for Mooren ulcer?
They may be considered when the ulcer continues to worsen despite eye drops or when both eyes are affected. Options can include oral steroids, methotrexate, cyclophosphamide, or cyclosporine, and the choice depends on the specialist’s assessment.
What warning signs could mean I have an infection during treatment?
New white or feathery areas on the ulcer, a milky change, discharge, increasing redness, worsening pain, or vision changes should be reported promptly. Herpes simplex virus and fungal infections can become more likely or harder to control when steroid or immune-suppressing treatment lowers the eye’s defenses.
What tests are needed with systemic Mooren ulcer medicines?
Depending on the medicine, monitoring may include regular blood counts and liver and kidney tests. Report fever, unusual bruising, or blood in the urine, and discuss pregnancy plans and vaccines with the prescribing team.
Can Mooren ulcer require surgery?
Yes. If the cornea is severely thinned, leaking, or close to perforating, cyanoacrylate glue may seal a small leak or a corneal transplant may be needed for structural support. Urgent repair can be required even before inflammation is fully quiet.
Why might a rheumatologist be involved in Mooren ulcer care?
A rheumatologist may help an ophthalmologist choose and monitor systemic immune-suppressing medicines, particularly when disease is bilateral, progressive, or difficult to control. Care is coordinated because these drugs can affect blood counts, the liver, the kidneys, and infection risk.
What happens if herpes simplex virus is found during Mooren ulcer treatment?
Doctors may add an antiviral such as acyclovir and adjust steroid or other immune-suppressing treatment so the infection does not spread. This balance must be directed by the treating specialist, and you should not start or restart steroid drops without medical advice.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Mooren ulcer.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current level of thinning, what is our individualized treatment plan?
  2. 2.If we start systemic drugs like methotrexate or cyclophosphamide, what blood tests will I need and how often?
  3. 3.Since steroids can mask infections, what specific warning signs should prompt me to call the office immediately?
  4. 4.Do I need to be seen by a rheumatologist to help prescribe and monitor systemic immunosuppressive medications?
  5. 5.What are the potential side effects of these medications regarding my liver, kidneys, and overall infection risk?

References

References (15)
  1. 1

    Mooren'S ulcer in ibadan, southwest Nigeria.

    Fasina O, Ogundipe A, Ezichi E

    Journal of the West African College of Surgeons 2013; (3(3)):102-19.

    PMID: 25717466
  2. 2

    Unilateral Mooren's ulcer in a patient with bilateral partial optic nerve atrophy - a case report.

    Macovei ML, Neacșu AM

    Romanian journal of ophthalmology 2022; (66(4)):360-364 doi:10.22336/rjo.2022.64.

    PMID: 36589320
  3. 3

    Anterior Segment Optical Coherence Tomography for the Tailored Treatment of Mooren's Ulcer: A Case Report.

    Lucchino L, Mastrogiuseppe E, Giovannetti F, et al.

    Journal of clinical medicine 2024; (13(18)) doi:10.3390/jcm13185384.

    PMID: 39336871
  4. 4

    Successful Management of Fungal Keratitis by Alternaria alternata Complicating Mooren's Ulcer.

    Todokoro D, Miyakubo T, Komori A, et al.

    Case reports in ophthalmology 2023; (14(1)):153-158 doi:10.1159/000529979.

    PMID: 37065728
  5. 5

    Herpes Viral Co-Infection in Benign Mooren's Ulcer.

    Cho YK, Kim DW

    Ocular immunology and inflammation 2026; 1-8 doi:10.1080/09273948.2026.2734627.

    PMID: 42745537
  6. 6

    Evaluation of a severity-based surgical strategy for refractory Mooren's ulcer: A retrospective series with long-term follow-up.

    Huang M, Wu Z, Wei D, et al.

    PloS one 2026; (21(9)):e0359413 doi:10.1371/journal.pone.0359413.

    PMID: 42814695
  7. 7

    Bilateral Mooren's Ulcer With Corneal Perforation in Two Women of Different Ethnicities: A Report of Two Cases.

    Balestrazzi A, Michieletto P, Michieletto M

    Cureus 2026; (18(7)):e112503 doi:10.7759/cureus.112503.

    PMID: 42583409
  8. 8

    Bilateral Mooren's ulcer - Customised corneal graft with additional amniotic membrane graft.

    Bhandari V, Siddharthan KS

    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2015; (29(3)):235-7 doi:10.1016/j.sjopt.2014.12.005.

    PMID: 26155087
  9. 9

    Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.

    Karaca I, Tran EM, Park S, et al.

    Journal of ophthalmic inflammation and infection 2024; (14(1)):12 doi:10.1186/s12348-023-00372-z.

    PMID: 38466527
  10. 10

    A case of refractory Mooren's ulcer successfully treated with systemic immunosuppressive therapy.

    Yumori-Matsunaka E, Araki-Sasaki K, Ishimoto A, et al.

    Immunological medicine 2026; 1-6 doi:10.1080/25785826.2026.2647494.

    PMID: 41884994
  11. 11

    Use of Systemic Mycophenolate Mofetil Therapy in Ocular Surface Inflammatory Pathologies at the Initiative and Responsibility of the Ophthalmologist.

    Furundaoturan O, Akçay P, Selver OB

    Middle East African journal of ophthalmology 2022; (29(4)):209-215 doi:10.4103/meajo.meajo_109_23.

    PMID: 38162558
  12. 12

    Management of severe and refractory Mooren's ulcers with rituximab.

    Guindolet D, Reynaud C, Clavel G, et al.

    The British journal of ophthalmology 2017; (101(4)):418-422 doi:10.1136/bjophthalmol-2016-308838.

    PMID: 27450147
  13. 13

    Effect of Anti-TNF Treatment on Mooren's Ulcer: A Case Series and Review of the Literature.

    Xia A, Dietrich-Ntoukas T, Pleyer U

    Ocular immunology and inflammation 2023; (31(4)):675-681 doi:10.1080/09273948.2021.2023581.

    PMID: 35050832
  14. 14

    The Complete Success in Refractory Mooren's Ulcer Treated with Infliximab.

    Çakmak Aİ, Akova Y, Yıldırım N

    Ocular immunology and inflammation 2023; (31(4)):682-688 doi:10.1080/09273948.2022.2091615.

    PMID: 35830240
  15. 15

    Efficacy of conjunctival resection with cyanoacrylate glue application in preventing recurrences of Mooren's ulcer.

    Lal I, Shivanagari SB, Ali MH, Vazirani J

    The British journal of ophthalmology 2016; (100(7)):971-975 doi:10.1136/bjophthalmol-2015-307350.

    PMID: 26553919

This page is for informational purposes only and does not constitute medical advice. An ophthalmologist, and when needed a rheumatologist, should tailor Mooren ulcer medicines, monitoring, and any urgent corneal repair to your situation.